ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2041

Single Cell Atlas of Minor Salivary Glands Reveals Key Differential Cellular and Functional Players in Sjögren’s and Sicca Syndrome

SABA NAYAR1, Jason D. turner1, Saba Asam1, Charlotte G. Smith1, Serena Colfrancesco2, Ana Teodósio1, Joe Flint1, David H Gardner1, Professor Simon Bowman3, Adam Croft1, Andrew Filer1, Benjamin A. Fisher1, Christopher Buckley4 and Francesca Barone5, 1University of Birmingham, Birmingham, United Kingdom, 2University of Rome, Rome, Italy, 3University Hospitals Birmingham, Birmingham, United Kingdom, 4University of Oxford, Oxford, United Kingdom, 5University of Birmingham, Needham, MA

Meeting: ACR Convergence 2022

Keywords: Sjögren's syndrome

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2022

Title: Sjögren's Syndrome – Basic and Clinical Science Poster

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Sjögren’s syndrome (SjS) shares a series of symptoms with non-SjS Sicca syndrome, a salivary gland disease characterised by glandular dysfunction and dryness. However, unlike SjS, Sicca is not defined by tertiary lymphoid structure (TLS) formation in the salivary glands. TLS germinal centres provide a local hub for the maturation and proliferation of auto-reactive B-cells and expansion of malignant B-cell clones. TLS that form within salivary glands (SGs) of SjS patients are associated with poor disease outcome, autoantibody production and lymphoma development. In contrast, some Sicca cases may be associated with poorly defined T cell infiltration in the absence of clear T/B cell aggregation without TLS formation. The cellular and biological processes that drive organ permissiveness for TLS establishment in SjS as opposed to Sicca are largely unclear, but could act as an exemplar for TLS formation at other sites.

Methods: Single cell atlases of SGs were generated from SjS and sicca (n=eight per group) patients using the 10x scRNAseq Genomics platform. SjS patients fulfilled 2016 ACR/EULAR classification criteria. Sicca patients were anti-Ro and biopsy negative for FLS, but displayed scattered T cell infiltration in some cases. Data analysis was performed using R and the harmony, Seurat and Cellchat packages. Multiplex IHC, RNAscope and quantitative-PCR were used to validate scRNAseq findings.

Results: Cell clustering of SjS and Sicca SGs unveiled key differences in both immune cells and stromal cell compartment between the two disease groups. Sicca samples had significant differences in the immune-cell compartment, in particular, sicca SGs lacked activated ICOS+IL17+IFNG+TNF+ CD4 T helper and presented major differences in the IL7R+CD8+ T and Treg population. Small numbers of poorly differentiated populations of B cells and plasma cells were detected in Sicca, as compared to SjS SGs. Both disease groups had populations of CD8+GranzymeK+CD8 T cells.

Sicca SGs lacked crucial alterations in their stromal cell populations including an absence of CXCL9+BAFF+CCL19+CCL21+CD40+ immunofibroblasts that are classically associated with SjS TLS. Whilst CD40 expression was broadly expressed across SjS cell clusters, limited expression of both CD40 and CD40L was observed in Sicca SG, supporting the clinical observations on the importance of the CD40/CD40L pathway in SjS pathology. Cellular interactome and in vitro analysis revealed complex interplay between LTBR, TNF, IFNγ and CD40 signals on both immune and stromal cell populations for TLS establishment. No major differences were observed in the presence of myeloid and pericyte populations between the two disease groups. Analysis of differentially expressed genes highlighted variances in activation and function of epithelial and endothelial cells. Interestingly, sicca presented a significant inflammatory signature on endothelial cells.

Conclusion: Our work is the first, systematic map and atlas of micro-anatomical and functional differences between SjS and Sicca providing critical insight in pathogenic players and therapeutic targets in these two different conditions.

Supporting image 1

Acknowledgment


Disclosures: S. NAYAR, None; J. turner, None; S. Asam, None; C. Smith, None; S. Colfrancesco, None; A. Teodósio, None; J. Flint, None; D. Gardner, None; P. Bowman, Novartis, AstraZeneca, AbbVie/Abbott, Galapagos; A. Croft, None; A. Filer, None; B. Fisher, Servier, Galapagos, Janssen, Novartis, Bristol-Myers Squibb(BMS); C. Buckley, None; F. Barone, Candel Therapeutics.

To cite this abstract in AMA style:

NAYAR S, turner J, Asam S, Smith C, Colfrancesco S, Teodósio A, Flint J, Gardner D, Bowman P, Croft A, Filer A, Fisher B, Buckley C, Barone F. Single Cell Atlas of Minor Salivary Glands Reveals Key Differential Cellular and Functional Players in Sjögren’s and Sicca Syndrome [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/single-cell-atlas-of-minor-salivary-glands-reveals-key-differential-cellular-and-functional-players-in-sjogrens-and-sicca-syndrome/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-atlas-of-minor-salivary-glands-reveals-key-differential-cellular-and-functional-players-in-sjogrens-and-sicca-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology